x

Germany

FamiCord services are provided by eticur

Hungary

FamiCord services are provided by Krio Intézet

Italy

FamiCord services are provided by FamiCord Italia

Latvia

FamiCord services are provided by Climes Sunu Banka

Lithuania

FamiCord services are provided by Famicord Suisse

Luxemburg

FamiCord services are provided by Stemlab

Poland

FamiCord services are provided by Polski Bank Komórek Macierzystych

Portugal

FamiCord services are provided by Crioestaminal

Romania

FamiCord services are provided by Biogenis

Spain

FamiCord services are provided by Sevibe

Switzerland

FamiCord services are provided by Stemlab

Turkey

FamiCord services are provided by Yaşam Bankası

Albania

FamiCord services are provided by Biosave

Bosnia & Herzegovina

FamiCord services are provided by Biosave

Croatia

FamiCord services are provided by Biosave

Denmark

FamiCord services are provided by Cellaviva

Egypt

FamiCord services are provided by Cell Safe Bank

Kosovo

FamiCord services are provided by Biosave

Macedonia

FamiCord services are provided by Biosave

Montenegro

FamiCord services are provided by Biosave

Serbia

FamiCord services are provided by Biosave

Slovenia

FamiCord services are provided by Biosave

Sweden

FamiCord services are provided by Cellaviva

Ukraine

FamiCord services are provided by UBSK

United Kingdom

FamiCord services are provided by Polski Bank Komórek Macierzystych

Новини

There is no translation available.

This information is addressed to the customers of the former service provider in connection with which we have been authorized as a contact point for the customers of the former service provider.

PBKM S.A.-parent company of FamiCord Group (“FamiCord”) is the largest family stem cells bank in Europe.

Samples of almost all families being customers of the former service provider were transferred in accordance with all technical and medical requirements in the year 2019 and 2020 from various European locations to the Warsaw facility.

In order to ensure the most accurate information regarding the quality of the transported samples, FamiCord Group had agreed to a proposal deriving from a group of Italian parents to have a third-party laboratory perform a series of viability and biocompatibility tests on samples of their children.

After months of intensive work, the tests have been completed and the results interpreted.

Those tests have proven beyond any doubt that the biological material did indeed belong to the owners and that it had been properly stored over the years.

In particular, the analysis of more than 200 viability and HLA test results proves conclusively that:

  • the cryopreservation process of the samples, coming from different periods of activity of the previous service provider, was carried out correctly - at this point, it should be noted that the panel of results obtained for cell viability excludes the hypothetical possibility of overheating and subsequent re-freezing of the samples in question
  • the stored material belongs to its legitimate owners - thus, through independent HLA testing, full biological compatibility was confirmed

In light of the above Famicord Group invites Italian parents to complete the necessary formalities and definitively settle the legal status of the stored biological material samples.

This can be done in three simple steps at the following link: https://client.famicordcryobank.ch/it/client/km/step-1.

If you have any questions or doubts please contact us at info@famicordcryobank.ch or call our support in Italian at +39 0289735043.

Famicord Team